Video
Anti-TNF-a Induced Skin Eruptions in Patients with IBD: Presentation & Clinical Approach in Children.
Dr. Amy Paller presents on the clinical presentation and management of anti-TNF-α–induced cutaneous eruptions in…
Dr. Amy Paller presents on the clinical presentation and management of anti-TNF-α–induced cutaneous eruptions in…
Watch VideoWhat were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis…
View ReportView Report
IPC Board Member Dr. Amy Paller highlights the under-recognition of psoriasis in children and pediatric patients. She…
Watch VideoConflicts of interest Dr Al-Gawahiri carried out clinical trials for Janssen. All funding is not personal but goes to…
View ReportDr. Satveer Mahil leads a panel of global psoriasis experts as they answer questions from the second and third parts of…
Watch VideoDr. Amy Paller highlights recent treatment developments in pediatric psoriasis, emphasizing this group's high rate of…
Watch VideoThe 33rd Annual EADV Congress in Amsterdam featured updates on psoriasis care, including highlights from the IPC…
Read MoreMeet Dr. Amy Paller, a leading pediatric dermatologist and researcher from Chicago, Illinois, and a Board Member of the…
Read MoreEUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY (EADV) | AMSTERDAM, NETHERLANDS Program chairs: Lone Skov, Denmark and…
Discover the latest additions to the IPC’s Board of Directors, key psoriasis leaders, André Carvalho and Amy Paller.…
Read More| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
IPC Councilor Helen Young provides commentary on a study identifying skin-derived myeloid precursors and CD200+ fibroblasts as key drivers of psoriatic disease spread from the skin to joints, highlighting the CD200–CD200R1 axis as a promising therapeutic target.
IPC Fellow Dr. Yemsrach Abawaji shares her firsthand perspective on the barriers to psoriasis diagnosis and treatment in Ethiopia and opportunities to improve care.
Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.
Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.